Illumina delivers 2021 results ahead of expectations, strong 2022 guidance and deep pipeline of long-term growth opportunities at 2022 J.P. Morgan Healthcare Conference

Multiple innovative partnerships with healthcare companies, research institutions, and multiomic developers, along with new groundbreaking technologies, including a new SBS chemistry and long-read capabilities, position Illumina to accelerate genomic adoption and improve human health globally SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) Chief Executive Officer, Francis deSouza, discussed today the company's strong growth trajectory, including 2021 [...]

SINGULAR GENOMICS PARTNERS WITH LEXOGEN TO ENABLE RNA LIBRARY PREP FOR THE G4 SEQUENCING PLATFORM

THIS PARTNERSHIP INTEGRATES G4’S ACCURACY, SPEED, FLEXIBILITY AND POWER WITH LEXOGEN’S EXPERTISE IN RNA LIBRARY PREPARATION KITS TO EMPOWER SPECIALIZED WORKFLOWS FOR CUSTOMERS. LA JOLLA, Calif. -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Lexogen to [...]

SINGULAR GENOMICS PARTNERS WITH NEW ENGLAND BIOLABS® TO ENABLE NEBNEXT® KITS FOR THE G4 SEQUENCING PLATFORM

THIS PARTNERSHIP INTEGRATES G4’S ACCURACY, SPEED, FLEXIBILITY AND POWER WITH THE NEBNEXT DNA AND RNA LIBRARY PREP KITS TO EMPOWER HIGH-QUALITY, ESTABLISHED WORKFLOWS FOR CUSTOMERS LA JOLLA, Calif. -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with [...]

SINGULAR GENOMICS PARTNERS WITH TWIST BIOSCIENCE TO ENABLE THE TWIST NGS TARGET ENRICHMENT SOLUTIONS FOR THE G4 SEQUENCING PLATFORM

THIS PARTNERSHIP INTEGRATES G4’S ACCURACY, SPEED, FLEXIBILITY AND POWER WITH THE TWIST TARGET ENRICHMENT SOLUTIONS TO EMPOWER FIXED AND CUSTOM TARGETED SEQUENCING PANELS FOR CUSTOMERS. LA JOLLA, Calif. -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with [...]

SINGULAR GENOMICS PARTNERS WITH WATCHMAKER GENOMICS TO ENABLE THE WATCHMAKER DNA LIBRARY PREP KITS FOR THE G4 SEQUENCING PLATFORM

THIS PARTNERSHIP INTEGRATES G4’S ACCURACY, SPEED, FLEXIBILITY AND POWER WITH THE WATCHMAKER DNA LIBRARY PREP KITS TO EMPOWER INNOVATIVE WORKFLOWS FOR CUSTOMERS LA JOLLA, Calif. -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Watchmaker Genomics to [...]

SINGULAR GENOMICS PARTNERS WITH DOVETAIL GENOMICS TO ENABLE DOVETAIL KITS FOR THE G4 SEQUENCING PLATFORM

THIS PARTNERSHIP INTEGRATES G4’S ACCURACY, SPEED, FLEXIBILITY AND POWER WITH DOVETAIL’S EXPERTISE IN 3-D GENOME ARCHITECTURE TO EMPOWER SPECIALIZED WORKFLOWS FOR CUSTOMERS. LA JOLLA, Calif. -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Dovetail Genomics to [...]

Berkeley Lights and Aanika Biosciences Announce Partnership to Improve Food Safety by Commercializing Antimicrobial Peptides through Proprietary High-Throughput, Functional Screening Service

EMERYVILLE, Calif. -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Aanika Biosciences, a growing biotech start-up using edible microbial tags to improve food safety, today announced a strategic partnership that will enable faster identification of outbreak sources, reduce incidents of fresh produce contamination and minimize the impact of food borne [...]

CliniSys acquires HORIZON Lab Systems, LLC a leading laboratory information management system (LIMS) provider

Acquisition extends CliniSys capabilities into new and complementary market sectors serving environmental, water quality testing, public health, toxicology, and agriculture The acquisition extends CliniSys’ laboratory testing, diagnostics, and management capabilities further into the public health sector and related markets, such as environmental, water quality testing, public health, toxicology, and agricultural testing. Additionally, the acquisition of [...]

Latest tools for COVID-19 Omicron variant research

AMSBIO has announced new additions to its portfolio of tools for COVID-19 research - two monoclonal antibodies that recognize the Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Research has shown that ACE2 mediates COVID-19 infection [...]

Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Excellence Program

Company has already booked multiple orders and established COEs in three major geographies REDWOOD CITY, Calif. -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced Broad Commercial Release of its Proteograph Product Suite and the launch of its Centers of Excellence program. The Proteograph Product Suite [...]

Access IBO on Knowledge Center